Short answer · Medically reviewed summary · Last updated: 2026-04-07
Machado-Joseph Disease is most commonly referred to as Spinocerebellar Ataxia Type 3 (SCA3). While historical literature may use various regional or eponym-based titles, the medical community now utilizes the SCA3 nomenclature to reflect the underlying genetic mutation in the ATXN3 gene. Why does Machado-Joseph Disease have multiple names? The naming of Machado-Joseph Disease reflects its complex history of discovery.
Machado-Joseph Disease is most commonly referred to as Spinocerebellar Ataxia Type 3 (SCA3). While historical literature may use various regional or eponym-based titles, the medical community now utilizes the SCA3 nomenclature to reflect the underlying genetic mutation in the ATXN3 gene.
The naming of Machado-Joseph Disease reflects its complex history of discovery. Initially, researchers identified the condition in different families and regions, assigning names based on the surnames of the affected individuals or the geographic location of the discovery. As genetic testing evolved, researchers realized these seemingly distinct conditions were actually the same genetic disorder. Today, the medical community prefers the term Spinocerebellar Ataxia Type 3 (SCA3) because it classifies the condition based on the specific genomic location of the mutation, providing more diagnostic clarity than the historical eponyms.
If you are reviewing older medical records or international literature regarding Machado-Joseph Disease, you may encounter several different terms. Understanding these synonyms is vital for ensuring you have the correct information when researching your diagnosis. Common alternative names include:
For official documentation and international classification, Machado-Joseph Disease is categorized using specific medical codes. In the International Classification of Diseases (ICD-10/11), it falls under the broader category of hereditary ataxias. In the Online Mendelian Inheritance in Man (OMIM) database, it is cataloged as #109150. Meanwhile, the Orphanet portal—the reference resource for rare diseases—uses the identifier ORPHA537. These classification systems ensure that Machado-Joseph Disease is tracked consistently across global healthcare systems, facilitating better data collection and research coordination.
While Machado-Joseph Disease remains a respectful and commonly used term in patient advocacy, medical professionals increasingly favor "SCA3." This preference exists because SCA3 describes the underlying pathology: a CAG trinucleotide repeat expansion in the ATXN3 gene. Because this genetic mechanism is the definitive feature of the condition, using the term SCA3 helps clinicians differentiate it from other types of spinocerebellar ataxias that present with similar movement disorders but involve different genetic pathways. At DiseaseMaps.org, we recognize that 42 community members currently connect through their shared experience with Machado-Joseph Disease, and we support the use of both terms to ensure patients can find the community and resources they need.
Medical disclaimer: This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.